Relevant bibliographies by topics / Myastenia Gravis / Journal articles
To see the other types of publications on this topic, follow the link: Myastenia Gravis.

Journal articles on the topic 'Myastenia Gravis'

Author: Grafiati
Published: 4 June 2021
Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 42 journal articles for your research on the topic 'Myastenia Gravis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Evlice, Ahmet, Turgay Demir, and Filiz Koç. "Myastenia Gravis ve Gebelik." Arşiv Kaynak Tarama Dergisi 25, no. 1 (February 1, 2016): 33. http://dx.doi.org/10.17827/aktd.50846.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fendy Dwimartyono. "Nyeri Neuropatik Pada Penderita Myastenia Gravis." Green Medical Journal 1, no. 1 (December 1, 2019): 111–27. http://dx.doi.org/10.33096/gmj.v1i1.25.

Full text
Abstract:
Miastenia gravis (MG) adalah suatu bentuk kelainan pada transmisi neuromuskular yang paling sering terjadi. Kelainan pada transmisi neuromuskular yang dimaksud adalah penyakit pada neuromuscular junction (NMJ). MG adalah suatu penyakit autoimun dimana tubuh secara salah memproduksi antibodi terhadap reseptor asetilkolin (AChR) sehingga jumlah AchR di NMJ berkurang. MG menyebabkan permasalahan transmisi yang mana terjadi pemblokiran AchR di serat otot (post synaptic) mengakibatkan tidak sampainya impuls dari serat saraf ke serat otot sehingga menyebabkan tidak terjadinya kontraksi otot. MG ditandai oleh kelemahan otot yang kembali memulih setelah istirahat. Otot yang paling sering terkena adalah ekstraokular, tungkai, wajah dan otot leher. Miastenia dalam bahasa latin artinya kelemahan otot dan gravis artinya parah
APA, Harvard, Vancouver, ISO, and other styles
3

Biricik, Ebru. "Myastenia gravis tanılı hastada sugammadex kullanımı." Ege Tıp Dergisi 55, no. 2 (June 1, 2016): 82–83. http://dx.doi.org/10.19161/etd.344187.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ehler, Edvard, and Jiří Piťha. "Myasthenia gravis with anti-MuSK antibodies." Neurologie pro praxi 18, no. 5 (November 1, 2017): 314–17. http://dx.doi.org/10.36290/neu.2017.104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Storm-Mathisen, A. "EPIDEMIOLOGICAL ASPECTS OF MYASTENIA GRAVIS IN NORWAY." Acta Neurologica Scandinavica 65, S90 (January 29, 2009): 135–36. http://dx.doi.org/10.1111/j.1600-0404.1982.tb03418.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Romanova, T. V. "Sleep disorders in patients with myastenia gravis." Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121, no. 4 (2021): 92. http://dx.doi.org/10.17116/jnevro202112104292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Horáková, Magda, and Stanislav Voháňka. "Scales and questionnaires used in myasthenia gravis." Neurologie pro praxi 18, no. 5 (November 1, 2017): 301–4. http://dx.doi.org/10.36290/neu.2017.035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Xu, X. H., Z. Wu, B. Y. Xu, W. Y. Li, W. Y. Gu, Y. K. Hu, Y. Li, et al. "Myastenia gravis is essentially a generalized autoimmune disorder." Journal of Neuroimmunology 35 (January 1991): 101. http://dx.doi.org/10.1016/0165-5728(91)91026-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kalbus, O. I. "Markers of quality of life in patients with myastenia gravis." Bukovinian Medical Herald 23, no. 2 (90) (June 30, 2019): 3–9. http://dx.doi.org/10.24061/2413-0737.xxiii.2.90.2019.26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

KUNIEDA, Katsuyuki, Shigeyuki TAKEMURA, Motohisa KATOH, Yasuyuki SUGIYAMA, Matahiko MURASE, Kuniyasu SHIMOKAWA, and Shigetoyo SAJI. "A CASE OF RETROPERITONEAL CASTLEMAN'S LYMPHOMA ACCOMPANIED WITH MYASTENIA GRAVIS." Journal of the Japanese Practical Surgeon Society 58, no. 3 (1997): 672–76. http://dx.doi.org/10.3919/ringe1963.58.672.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Ozel, Funda, Ali Aydin Altunkan, and Mustafa Azizoglu. "Postoperative Respiratory Failure in a Patient with Undiagnosed Myastenia Gravis." Turkish Journal of Anesthesia and Reanimation 44, no. 2 (May 27, 2016): 108–10. http://dx.doi.org/10.5152/tjar.2016.03274.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Farid, Zahratul Riadho, and Devi Azri Wahyuni. "Factors Affecting Generalization of Ocular Myasthenia Gravis in Palembang." Sriwijaya Journal of Ophthalmology 3, no. 2 (March 25, 2021): 75–84. http://dx.doi.org/10.37275/sjo.v3i2.55.

Full text
Abstract:
Introduction. Ocular myasthenia gravis (OMG) is an autoimmune disease which is characterized by weakness of extraocular muscles, levator palpebrae and orbicularis oculi, resulting in ptosis and binocular diplopia. Nearly all patients present with eyelid and extra ocular muscles involvement. Approximately 30% to 80% of patients with OMG experience a conversion to generalized myasthenia gravis (GMG) within 2 years. There are not only have ptosis and diplopia but also limb weakness,bulbar symptoms, or even respiratory failure. Objective. To observe the clinical features of OMG to GMG and risk factors and median time to conversion of OMG to GMG of myasthenia gravis patients in Mohammad Hoesin General Hospital Palembang. Method. This study is a cohort retrospective study and the data were collected from the medical records of 91 patients who were registered as myasthenia gravis patients during September 2018 to March 2020. Sosiodemographic and clinical characteristics, including onset of OMG to GMG, history of smoking, presence of thymic abnormalities, and medications received were reviewed retrospectively. Result. A total of 91 OMG patients were observed in this study with 32 (35,2%) patients converted from ocular myastenia gravis to general myastenia gravis. Median conversion time to GMG was 34 months. Risk factor for convertion cases of OMG to MGG was receiving immunosupressive agents(Risk: 14.7, 95% CI 4.83, 44.7), thymus hyperplasia (Risk: 3.36, CI 95% 0.33, 33.6), Female (Risk: 2.41, 95% CI 0.94, 6.17), Smoking (Risk: 1.56, 95% CI 0.31, 7.81). Conclusion. Ptosis was the definitive sign for OMG in this study, with all patients had ptosis, thus it needs the colaboration from neuroophthalmologist and neurologist to diagnose and manage this case. Most of converted case was female and those who receive an immunosupressive agent therapy.
APA, Harvard, Vancouver, ISO, and other styles
13

Sipahi, Savas, Ozkan Gungor, Selcuk Yaylaci, Ahmet Bilal Genc, Hakan Demirci, Mustafa Volkan Demir, and Ali Tamer. "Nephrotic Syndrome in a Patient with Myastenia Gravis Under Immunosupressive Therapy." Turkish Nephrology Dialysis Transplantation 20, no. 03 (September 19, 2011): 307–9. http://dx.doi.org/10.5262/tndt.2011.1003.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Teodorescu, Andreea, Petru Ifteni, Paula Petric, Sebastian Toma, Adrian Baracan, Claudia Gavris, Gheorghe G. Balan, Vladimir Poroch, and Alina Mihaela Pascu. "Acetylcholinesterase Inhibitors Test Confirmed Myasthenia Gravis in Psychosis Remitted by Aripiprazole." Revista de Chimie 68, no. 12 (January 15, 2018): 2952–54. http://dx.doi.org/10.37358/rc.17.12.6014.

Full text
Abstract:
Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease affecting the neuromuscular junction and causes weakness in the skeletal muscles. The acetylcholine receptor is usually attacked in skeletal muscles, but other components of neuromuscular junction, such as muscle-specific receptor tyrosine kinase, may be affected. MG can be life-threatening when the respiratory muscles are involved. The first symptom in about 2 out of 3 cases is the damage of the extrinsic eye muscles. The condition is treatable, so an early recognition is needed. Although there have been reports of associations between psychosis and myasthenia gravis it is unclear if psychotic symptoms in MG are an integral part of the various manifestations of this disease, or are due to another co-occurring distinct disorder. Sometimes psychotic episodes could disguise the simptoms of myastenia gravis, and delay the diagnosis.
APA, Harvard, Vancouver, ISO, and other styles
15

Duman, O., K. Resit, S. Haspolat, and H. Topaloglu. "P16.7 Infantile onset anti-musk positive myastenia gravis: report of two cases." European Journal of Paediatric Neurology 15 (May 2011): S97. http://dx.doi.org/10.1016/s1090-3798(11)70335-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Tuğcugil, Ersagun, Tahir Ersöz, Ahmet Şen, and Abdullah Özdemir. "Myastenia gravis li hastada KOAH alevlenmesine bağlı solunum yetmezliğinde yoğun bakım takibi." Genel Tip Dergisi 24, no. 2014/Ek2 (January 2, 2015): 33. http://dx.doi.org/10.15321/geneltipder.20152014/ek28552.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Somnier, F. E., W. Szpirt, H. Kjersem, S. Gammeltoft, and G. Boysen. "RAPID IMPROVEMENT OF MYASTENIA GRAVIS WITH A NEW TECHNIQUE OF PLASMA EXCHANGE:." Acta Neurologica Scandinavica 65, S90 (January 29, 2009): 132–33. http://dx.doi.org/10.1111/j.1600-0404.1982.tb03416.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Malkan, Ü. Y., G. Güneş, A. Işık, E. Eliaçık, N. Sayınalp, H. Demiroğlu, H. Göker, and İ. Haznedaroğlu. "PP-058 MYASTENIA GRAVIS AND WALDENSTROM MACROGLOBULINEMIA: IS COMMON IMMUNOLOGIC MECHANISM POSSIBLE?" Leukemia Research 38 (October 2014): S46. http://dx.doi.org/10.1016/s0145-2126(14)70112-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Aysal, F., S. Baybas, H. H. Selçuk, V. Sozmen, M. Ozturk, H. Kucukoglu, and N. H. Urer. "Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: Three years follow up." Clinical Neurology and Neurosurgery 115, no. 5 (May 2013): 628–31. http://dx.doi.org/10.1016/j.clineuro.2012.06.016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Zuffi, M., C. Antozzi, P. Confalonieri, P. Bernasconi, F. Baggi, F. Andreetta, A. Tagger, et al. "Prevalence and genotypes of hepatitis C virus in an Italian myastenia gravis population." Neuromuscular Disorders 4, no. 5-6 (September 1994): S10. http://dx.doi.org/10.1016/0960-8966(94)90112-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Piccolo, G., G. Martino, A. Moglia, A. Arrigo, and V. Cosi. "Autoimmune myastenia gravis with thymoma following the spontaneous remission of stiff-man syndrome." Italian Journal of Neurological Sciences 11, no. 2 (April 1990): 177–80. http://dx.doi.org/10.1007/bf02335562.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Pozzato, P., G. Sorrenti, F. Salvi, and M. Ventrucci. "PA.115 VON HIPPEL-LINDAU DISEASE ASSOCIATED WITH MYASTENIA GRAVIS NOT RELATED TO THYMOMA." Digestive and Liver Disease 40 (March 2008): S117. http://dx.doi.org/10.1016/s1590-8658(08)60310-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Sun, Changyuan, Fanping Meng, Yingxin Li, Quanxin Jin, Honghua Li, and Fangfang Li. "Antigen-specific Immunoadsorption of Anti-acetylcholine Receptor Antibodies from Sera of Patients with Myastenia Gravis." Artificial Cells, Blood Substitutes, and Biotechnology 38, no. 2 (January 2010): 99–102. http://dx.doi.org/10.3109/10731191003634778.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Rivero, A., L. Crovetto, L. Lopez, R. Maselli, and M. Nogués. "SFEMG of the superior rectus and levator palpebralis muscles in the diagnosis of ocular myastenia gravis." Electroencephalography and Clinical Neurophysiology 87, no. 2 (August 1993): S103. http://dx.doi.org/10.1016/0013-4694(93)91335-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Assis, J. Lamartine de, Paulo E. Marchiori, Antonio A. Zambon, Nagib Curi, Luiz Tarcisio Brito Filomeno, and Milberto Scaff. "Immunosupression with corticosteroids and thymectomy in myastenia gravis: an evaluation of immediate and short term results in 20 patients." Arquivos de Neuro-Psiquiatria 43, no. 1 (March 1985): 17–21. http://dx.doi.org/10.1590/s0004-282x1985000100003.

Full text
Abstract:
A comparatice study was conducted on two groups of patients with the generalized severe form of myasthenia gravis. The first group of 20 patients received oral daily doses of 60-100 mg of prednisone prior to thymectomy. The control group of 20 were submitted to surgery without prior corticosteroid treatment. The study included statistical analysis of the clinical results and surgical complications for both groups. The author concluded that the use of steroids preoperatively is beneficial.
APA, Harvard, Vancouver, ISO, and other styles
26

Dural, Koray, Nesimi Günal, Bülent Koçer, Gültekin Gülbahar, and Bilge Koçer. "Comparison of the postoperative first and fifth year outcomes in patients who had undergone thymectomy for Myastenia Gravis." Turkish Journal of Clinics and Laboratory 6, no. 2 (September 14, 2015): 49. http://dx.doi.org/10.18663/tjcl.59867.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Imai, Kohzoh, Kentaro Yamashita, Toshiaki Hayashi, Rieko Murakami, Hiroki Takahashi, Toshiro Sugiyama, Susumu Chiba, and Akira Yachi. "A case of chronic fatigue syndrome showing symptoms and signs with resemblance to Sjoegren's syndrome and myastenia gravis." Japanese Journal of Clinical Immunology 16, no. 4 (1993): 324–28. http://dx.doi.org/10.2177/jsci.16.324.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Ranjan*, Navi, and Manorma Kumari. "Acetylcholinesterase inhibition by medicinal plants: A Review." Annals of Plant Sciences 6, no. 06 (June 2, 2017): 1640. http://dx.doi.org/10.21746/aps.2017.06.003.

Full text
Abstract:
Acetylcholinesterase (AChE), the predominant cholinesterase in the brain, hydrolyzes ACh to choline and acetate, thereby terminating the effect of this neurotransmitter at cholinergic synapses. Therefore, AChE is the target of cholinesterase inhibitors used for addressing the cholinergic deficit in Alzheimer’s disease (AD) patients. Despite decades of research and advances in our understanding of its aetiology and pathogenesis, current pharmacotherapeutic options for AD are still very limited and represent an area of need that is currently unmet. The leading AD therapeutics involves AChE inhibitors, resulting in increased acetylcholine concentrations in the synaptic cleft and enhanced cholinergic transmission. Compounds showing an AChE inhibitory effect are also used for the treatment of senile dementia, myastenia gravis, Parkinson’s disease and ataxia. Taking into account that the inhibition of AChE has been one of the most used strategies for treating AD and that existing drugs are effective only against mild to moderate type of disease while presenting considerable side effects, the search for new sources of effective and selective anti acetylcholinesterase agents with fewer side effects is imperative. Various plants and phytochemical substances have demonstrated AChE inhibitory activity and thus could be beneficial in the treatment of neurodegenerative disorders such as AD.
APA, Harvard, Vancouver, ISO, and other styles
29

Kravchenko, V., A. Chumak, K. Loganovsky, I. Diagil, and V. Kuzmenko. "Myastenia and small doses of ionizing radiation: experience of successful use of rituximab for treatment of an irradiated with myasthenia gravis." Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology 22 (2017): 395–405. http://dx.doi.org/10.33145/2304-8336-2017-22-395-405.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Voháňka, Stanislav, and editor hlavního tématu. "Myastenie gravis." Neurologie pro praxi 18, no. 5 (November 1, 2017): 299. http://dx.doi.org/10.36290/neu.2017.024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Triggiani, Vincenzo, Edoardo Guastamacchia, Ivan Lolli, Giuseppe Troccoli, Francesco Resta, Carlo Sabbà, Nadia Ruggieri, and Emilio Tafaro. "Association of a Wide Invasive Malignant Thymoma with Myastenia Gravis and Primary Hyperparathyroidism Due to Parathyroid Adenoma: Case Report and Review of the Literature." Immunopharmacology and Immunotoxicology 28, no. 2 (January 2006): 377–85. http://dx.doi.org/10.1080/08923970600809587.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Sevinc, Cuneyd, Muhsin Balaban, Orkunt Ozkaptan, Ugur Yucetas, and Tahir Karadeniz. "The management of total avulsion of the ureter from both ends: Our experience and literature review." Archivio Italiano di Urologia e Andrologia 88, no. 2 (July 4, 2016): 97. http://dx.doi.org/10.4081/aiua.2016.2.97.

Full text
Abstract:
Objective: To evaluate the treatment modalities of total ureteral avulsion and to clarify the risk factors of this serious complication. Methods: This study retrospectively analyzed the data of 3 patients with complete ureteral avulsion during ureteroscopy. Of the three patients, two had distal ureteral complete avulsion, and one total ureteral avulsion on both ends. Ureteroneocystostomy (UNC) was immediately performed after distal ureteral avulsion cases. Ileal ureter substition was performed on the same session after the total ureteral avulsion in both ends. Two of the patients were under chronic use of corticosteroid treatment due to diagnosis of idiopathic trombocytopenic purpura and myastenia gravis and all patients had unsuccesful shockwave litotripsy (SWL) treatment history with at least 1 month period before surgery. Results: The patient who had ileal ureter substitution was followed at 3-month intervals by ultrasonography and renal function tests and she was uneventful after a 2 year follow-up period. The patients treated with UNC were followed up at 3 month interval by ultrasonography and renal function tests. They had normal renal function 1 year after the operation Conclusion: Complete ureteral avulsion is a rare but severe complication. Treatment modality can vary and ileal ureter can be applied succesfully in the total ureter avulsion in both ends when bladder capacity is not enough for a Boari flap. Failed SWL and/or corticosteroid treatment history of patients seems to increase the risk of the ureteral avulsion.
APA, Harvard, Vancouver, ISO, and other styles
33

Voháňka, Stanislav, and Magda Horáková. "Myasthenia gravis and anesthesia." Neurologie pro praxi 18, no. 5 (November 1, 2017): 306–8. http://dx.doi.org/10.36290/neu.2017.102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Horáková, Magda, and Stanislav Voháňka. "Challenges of ciclosporin and azathioprin dosage for myasthenia gravis." Neurologie pro praxi 18, no. 5 (November 1, 2017): 309–13. http://dx.doi.org/10.36290/neu.2017.103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Lavrnic, Dragana, Marija Romic, Aleksandra Kacar, Vidosava Rakocevic-Stojanovic, Zorica Stevic, Ana Vujic, Ivana Basta, Ivan Marjanovic, Gradimir Bogdanovic, and Slobodan Apostolski. "High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome." Vojnosanitetski pregled 63, no. 1 (2006): 37–42. http://dx.doi.org/10.2298/vsp0601037l.

Full text
Abstract:
Background/Aim. High doses of immunoglobulin G (IVIG) have been recognized as a very important therapeutic modality in the treatment of neurological diseases. The aim of this report was to present our experience in the treatment of severe forms of myasthenia gravis (MG) and Guillain-Barr? syndrome (GBS). Methods. We analyzed the efficacy and safety of immunoglobulin G therapy in 53 patients with severe forms of myasthenia gravis, and 27 patients with very severe forms of Guillain-Barr? syndrome. Results. At the end of the follow-up period, a significant improvement was noticed in 47 out of 53 patients with myasthenia gravis ( 88.7%). In the group of 27 patients with severe forms of Guillain-Barr? syndrome an improvement was registered in 19 patients (70.3%). The side effects of this therapy were mostly mild, manifested as headache, myalgia, skin rash, adynamia, and other clinically insignificant effects. No severe side effects were recognized. Conclusions. Our study clearly demonstrated the high efficacy of IVIG therapy in the treatment of severe forms of myastehnia gravis and Guillain-Barr? syndrome.
APA, Harvard, Vancouver, ISO, and other styles
36

Kalbus, O. I. "Evaluation of Disability as a Result of Myastena Gravis in Ukraine." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 4, no. 6 (October 13, 2019): 223–28. http://dx.doi.org/10.26693/jmbs04.06.223.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Irfan, Ferdy, and Susanthy Djajalaksana. "Myastehenia Gravis is Caused by the Thymoma in Anterosuperior Mediastinum Sinistra and Posteroinferior Sinistra." Malang Respiratory Journal 1, no. 1 (January 7, 2019): 34–40. http://dx.doi.org/10.21776/ub.mrj.2019.001.01.6.

Full text
Abstract:
Background: Thymoma is the most common thymus tumor; it covers 30% of the anterior mediastinum mass in adult. Almost half of thymoma does not present with any symptom and is found by accident. In 40% of patients have symptom of myasthenia gravis; other symptoms include chest pain, symptoms of bleeding and compression to other mediastinum’s structures. Ninety percent of thymoma is located in anterior mediastinum. Case: A 42-year-old woman came to Saiful Anwar Hospital with a complaint of difficulty in swallowing since three months before admission. We performed physical examination and chest X-ray AP’ and the result was within normal limit. In USG examination, there was no abnormality. From the laboratory examination, we found leucocytosis and from the CT-scan imaging, we found pocketed pleural effusion sinistra at the postero-inferior part. Based on these findings, we diagnosed (pre-operation diagnosis) this patient as anterosuperior mediastinum tumor: suspect thymoma. The pulmonologist consulted to Surgical Department for surgery. The surgeon performed sternotomy-tumor excision. The result from the vries coup and histopathogical examination was thymoma. FOB after the surgery showed an edema at the right vocal cord (post-extubation). Post-operative chest X-ray showed no mass in antero-superior mediastinum.
APA, Harvard, Vancouver, ISO, and other styles
38

Ozkan, Berker, and Alper Toker. "MYASTENIA GRAVIS AND VIDEOTHORACOSCOPIC THYMECTOMY." Toraks Cerrahisi Bulteni, March 1, 2012, 35–40. http://dx.doi.org/10.5152/tcb.2012.03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

YILMAZ, Arzu, Zahide YALAKİ, Zeynep ŞEN, and Bülent ALİOĞLU. "A Myasthenia Gravis Case Presenting with Bulbar Symptoms." Turkish Journal of Pediatric Disease, August 10, 2017. http://dx.doi.org/10.12956/tjpd.2017.292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

"Myastenia Gravis Patent Ductus Arteriosus: Ibuprofen Therapy Prescribing by Pharmacists." Hospital Pharmacy 39, no. 4 (April 2004): 389–92. http://dx.doi.org/10.1177/001857870403900417.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Peters, SA, SP Lemburg, P. Mohr, V. Nicolas, and CM Heyer. "CT-Befunde des Thymus bei Myastenia gravis und ihre Korrelation zu Patientencharakteristika, klinischen Symptomen, Funktionstests und histopathologischen Resultaten." RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 180, S 1 (2008). http://dx.doi.org/10.1055/s-2008-1074006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Aksun, Murat, Senem Girgin, Ufuk Yetkin, Volkan Kuru, Birzat Emre Gölboyu, Ali Gürbüz, and Nagihan Karahan. "Anesthetic Management in a Case with Myastenia Gravis Who Underwent Simultaneously Coronary Artery Bypass Graft (CABG) Surgery and Thymectomy." Journal of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care Society, 2014. http://dx.doi.org/10.5222/gkdad.2014.045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography